FDA updates guidance on COVID-19 convalescent plasma
The Food and Drug Administration yesterday updated its guidance and webpage on COVID-19 convalescent plasma.
The updates include recommendations on when individuals who have received an investigational COVID-19 vaccine qualify as convalescent plasma donors, and extend the period of enforcement discretion described in the guidance.
In addition, FDA yesterday posted updated information for blood establishments regarding the COVID-19 pandemic and blood donation.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…